Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-01-13
1996-02-13
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546276, A01N 4340
Patent
active
054911532
ABSTRACT:
The present invention is directed to a new class of 3-amido and 3-sulfamido-indolyl NMDA antagonists and their use in the treatment of a number of disease states.
REFERENCES:
patent: 4675332 (1987-06-01), Connor et al.
patent: 4774240 (1988-09-01), Boshagen et al.
patent: 4960786 (1990-10-01), Salituro et al.
patent: 5051442 (1991-09-01), Salituro et al.
patent: 5106847 (1992-04-01), Salituro et al.
Salituro et al. Chem. Abstr. vol. 116 entry 83486a (1991).
Bailey, J. Chem Soc. Perkin I (1973) pp. 1602-1606.
Monge et al., J. Hetero. Chem. 24 pp. 437-439 (1987).
Salituro et al., Bioorg. Med. Chem. Lett. 1 pp. 455-460 (1991).
Robinson et al. FASEB 0002, vol. 1, pp. 446-455 (1987).
Dingledine et al, TIPS vol. 11 pp. 334-338 (1990).
Greenamyre, Arch. Neurol. vol. 43, pp. 1056-1063 (1986).
Olney, Biol. Pschiatry vol. 26, pp. 505-525 (1989).
Baron Bruce M.
Salituro Francesco G.
Daus Donald G.
Merrell Dow Pharmaceuticals Inc.
Sayles Michael J.
LandOfFree
3-amidoindolyl derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-amidoindolyl derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-amidoindolyl derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-240835